Skip to main content
Clinical Trials/NCT05907200
NCT05907200
Completed
Not Applicable

Ultrasound in Combination With Manual Therapy in the Treatment of Ischemic Digital Ulcers in Systemic Sclerosis

University of Palermo1 site in 1 country45 target enrollmentApril 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Systemic Sclerosis
Sponsor
University of Palermo
Enrollment
45
Locations
1
Primary Endpoint
functional capacity
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The objective of this before-after non-randomized trial study is to evaluate the efficacy of ultrasound therapy in combination with manual therapy in the management of systemic sclerosis patients with IDU. The main questions it intends to answer are:

• Is this combination of treatments effective in these patients in terms of improvement in hand functional ability, pain relief, injury healing, and quality of life?

Participants will receive rehabilitation treatment consisting of a combination of manual therapy (McMennel joint manipulation, pumping, and connective tissue massage) and US water immersion. The researchers will compare the group of participants, called the treatment group, with a control group to see if:

• Is the combined treatment of ultrasound therapy and manual therapy more effective in these patients than manual therapy alone?

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
December 15, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Prof.ssa Giulia Letizia Mauro

Professor

University of Palermo

Eligibility Criteria

Inclusion Criteria

  • diagnosis of SSc according to the ACR and EULAR criteria
  • presence of IDU in active phase
  • naïve to rehabilitation treatment for their hands and upper limbs
  • written in-formed consent to participate in the study.

Exclusion Criteria

  • presence of skin lesions due to other conditions (e.g., trauma);
  • pregnancy;
  • infectious diseases (e.g. HIV, HBV, HCV);
  • myositis;
  • arthritis;
  • other rheumatological diseases and immunodepression.

Outcomes

Primary Outcomes

functional capacity

Time Frame: after 4 weeks of treatment

Duruoz's hand index. The total score ranges from 0-90 with higher scores indicating poorer hand functioning.

Secondary Outcomes

  • disease-related quality of life(after 4 weeks of treatment)
  • ulcer assessment(after 4 weeks of treatment)
  • pain intensity(after 4 weeks of treatment)

Study Sites (1)

Loading locations...

Similar Trials